Skip to main content Back to Top

Reframing the Conversation Surrounding Harms Reduction and How to Check Your Stigma

June 2, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment.


Paige MatthewPaige Mathew, PharmD, BCPS, BCGP oversees pain management and opioid safety programs for Veterans across Washington DC, Maryland, and West Virginia in her role as clinical program manager in the Department of Veterans Affairs Healthcare System. She focuses on optimizing medication regimens for patients diagnosed with chronic pain or cancer. By supporting harm reduction strategies and combating the stigma surrounding the treatment of substance use disorders, her work addresses disparities in access to care. 

Bayli LarsonBayli Larson, PharmD, MS, BCPS is strategic initiatives associate at ASHP. In her role she helps manage and lead a variety of collaborative cross-organizational strategic activities to help advance ASHP’s mission and vision and is also co-coordinator of the ASHP Executive Fellowship in Association Leadership and Management. She completed her PGY1 residency at UCHealth Memorial Hospital in Colorado Springs, Colo., and earned her PharmD from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.